Acute Ischemic Stroke Diagnosis and Treatment Market Analysis and In-depth Research on Market Size, Trends, Emerging Growth Factors and Regional Forecasts to 2023

Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Heart attacks and strokes respectively account for the highest number of deaths due to cardiovascular diseases, globally. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes.

Stroke is one of the leading cause of long term disability, occurring at a higher rate in the old age population. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-toc-and-sample/1440

KEY MARKET BENEFITS:

• Comprehensive analysis of factors that drive and restrict the growth of the global acute ischemic stroke diagnosis and treatment market is provided

• The report provides a comprehensive analysis of the current market and estimations through 20142020, which would enable the stakeholders to capitalize on prevailing market opportunities

• An in-depth analysis of the key segments of the market demonstrate the types of therapeutics along with the diagnostics that currently used in the acute ischemic stroke market

• SWOT analysis highlights the internal environment of leading companies for effective strategy formulation

• The acute ischemic stroke diagnosis and treatment market scenario is comprehensively analysed in accordance to the key regions

• Competitive intelligence highlights the business practises followed by leading market players across geographies

The two major factors propelling the growth of the acute ischemic stroke diagnosis and treatment market are; large patient pools and a concerning rise in population at a higher risk of developing stroke in the near future. Rising incidence of diabetes along with heavy tobacco users and an increase in the ageing population are significant factors that determine the market growth. However, the high cost of treatment, lack of transparent reimbursement policies, and limited availability of expertise; are likely to restrict the market growth.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/1440

Top key players :

• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Cordis Corporation
• Koninklijke Philips N.V.
• GE Healthcare
• Siemens AG
• Stryker Corporation
• Genentech Inc.
• Merck & Co. Inc.

New Product launches and collaborations are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery through a minimally invasive technique. NeuroVive Pharmaceutical AB, entered into collaboration with BBB Therapeutics, for development of the NVP014 drug candidate used in the treatment of ischemic strokes.

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/acute-ischemic-stroke-diagnosis-and-treatment-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.